These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25776891)

  • 21. Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.
    Simon TG; Trejo MEP; Zeb I; Frazier-Wood AC; McClelland RL; Chung RT; Budoff MJ
    Metabolism; 2017 Oct; 75():1-5. PubMed ID: 28964324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.
    Long MT; Wang N; Larson MG; Mitchell GF; Palmisano J; Vasan RS; Hoffmann U; Speliotes EK; Vita JA; Benjamin EJ; Fox CS; Hamburg NM
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1284-91. PubMed ID: 25745056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis.
    Wilechansky RM; Pedley A; Massaro JM; Hoffmann U; Benjamin EJ; Long MT
    Liver Int; 2019 Aug; 39(8):1535-1544. PubMed ID: 31033142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
    Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study.
    Mahabadi AA; Massaro JM; Rosito GA; Levy D; Murabito JM; Wolf PA; O'Donnell CJ; Fox CS; Hoffmann U
    Eur Heart J; 2009 Apr; 30(7):850-6. PubMed ID: 19136488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
    Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
    Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
    Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
    Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of Risk Factors and Abdominal Aortic Calcium to Progression of Coronary Artery Calcium (from the Framingham Heart Study).
    Onuma OK; Pencina K; Qazi S; Massaro JM; D'Agostino RB; Chuang ML; Fox CS; Hoffmann U; O'Donnell CJ
    Am J Cardiol; 2017 May; 119(10):1584-1589. PubMed ID: 28442125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of fat density with subclinical atherosclerosis.
    Alvey NJ; Pedley A; Rosenquist KJ; Massaro JM; O'Donnell CJ; Hoffmann U; Fox CS
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25169793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Sarkar M; VanWagner LB; Terry JG; Carr JJ; Rinella M; Schreiner PJ; Lewis CE; Terrault N;
    Am J Gastroenterol; 2019 May; 114(5):758-763. PubMed ID: 30730350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex Differences in the Associations of Visceral Adipose Tissue and Cardiometabolic and Cardiovascular Disease Risk: The Framingham Heart Study.
    Kammerlander AA; Lyass A; Mahoney TF; Massaro JM; Long MT; Vasan RS; Hoffmann U
    J Am Heart Assoc; 2021 Jun; 10(11):e019968. PubMed ID: 33998254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.
    Long MT; Massaro JM; Hoffmann U; Benjamin EJ; Naimi TS
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1831-1841.e5. PubMed ID: 31734449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications.
    Pickhardt PJ; Hahn L; Muñoz del Rio A; Park SH; Reeder SB; Said A
    AJR Am J Roentgenol; 2014 Apr; 202(4):752-8. PubMed ID: 24660702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.
    Osawa K; Miyoshi T; Yamauchi K; Koyama Y; Nakamura K; Sato S; Kanazawa S; Ito H
    PLoS One; 2015; 10(6):e0131138. PubMed ID: 26125952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.
    Park JG; Jung J; Verma KK; Kang MK; Madamba E; Lopez S; Qas Yonan A; Liu A; Bettencourt R; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2021 May; 53(9):1030-1037. PubMed ID: 33764550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
    Miptah HN; Ramli AS; Mohamad M; Hashim H; Tharek Z
    BMC Fam Pract; 2020 Nov; 21(1):238. PubMed ID: 33218301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study.
    Park J; Kim G; Kim H; Lee J; Jin SM; Kim JH
    Cardiovasc Diabetol; 2022 Dec; 21(1):287. PubMed ID: 36564787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity.
    Kim SH; Park HY; Lee HS; Jung KS; Lee MH; Jhee JH; Kim TH; Lee JE; Kim HJ; Kim BS; Park HC; Lee BK; Choi HY
    Sci Rep; 2020 Jan; 10(1):1025. PubMed ID: 31974458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.